Ecs Botanics Holdings Ltd · ASX:ECS
Ecs Botanics — Investor Presentation (September 2021)
21 slides from Ecs Botanics's investor presentation, Sep 2, 2021
Slide 1: Investor Presentation
For personal use only I N V E S T O R P R E S E N T A T I O N ECS Botanics I N V E S T O R Holdings Ltd P R E S E N T A T I O N Australia’s fastest growing medicinal cannabis & hemp business ECS is a large scale cultivator and manufacturer ASX : ECS of white label medicinal cannabis products and own
Slide 2: Value Proposition
ECS Botanics 01 From Farm to Pharma 05 Low cost For personal use only Value Proposition. One of only two ASX listed GMP licensed producing Medicinal Outdoor cultivation at >50% lower production and capital Cannabis Cultivators. 600m2 costs. Customers can compete pharmaceutical facility with sizeable
Slide 3: Our 5 Year Journey
Our 5 Year Journey. For personal use only Success achieved What will success look over last like in next I N V E S T O R 2 years 3 years? P R E S E N T A T I O N Largest Cultivator of Medicinal Cannabis Producing >10,000kg of Medicinal Cannabis annually in Australia across two sites Recognised for b
Slide 4: Corporate Overview and Key Metrics
Corporate Overview For personal use only And Key Metrics. I N V E S T O R Shares on issue Share price Area licensed for Customers P R E S E N T A T I O N cultivation 862.98m(*) $0.036(1) 13 acres 20+ Market cap FY21 Revenue Gender Diversity $32.07m(1) $1.26m 50% (1)Share price of $0.036 (as at 1st S
Slide 5: ECS Botanics is a Green Investment Opportunity
ECS Botanics is a Green For personal use only Investment Opportunity. I N V E S T O R ECS’s sun grown cannabis is green P R E S E N T A T I O N 96x 54x 18x less energy than less energy than less water than indoor grows1 Greenhouse an indoor grow2 grown product1 Solar Additional Black Market heritage
Slide 6: Medicinal Cannabis – Strong Demand In Our Key Markets
Medicinal Cannabis – For personal use only Strong Demand In Our Key Markets. I N V E S T O R Australasia The legal European UK CBD market the P R E S E N T A T I O N Medicinal Cannabis Expenditure cannabis market predicted to rise from $100 is forecast to grow with a compound annual growth worlds se
Slide 7: Established Facilities Underpinning Operations
Established For personal use only Facilities Victoria I N V E S T O R Underpinning Operations. P R E S E N T A T I O N Two complimentary sites Low cost GACP operating synergistically Cannabis material sent for GMP Manufacturing Tasmania 7
Slide 8: Established Facilities Underpinning Operations: Victoria
Established Facilities For personal use only Underpinning Operations. Multiple licences from Office of I N V E S T O R Drug Control and Therapeutic Goods Administration P R E S E N T A T I O N Cultivation & 7 acres of R&D in Manufacturing high security progress to Site (GMP) facility on 170 identify
Slide 9: Established Facilities Underpinning Operations: Tasmania
Established Facilities For personal use only Underpinning Operations. Semi protected cropping and I N V E S T O R outdoor grow operations – significant capacity to scale P R E S E N T A T I O N Large scale 6 acre secure CBD and cultivation area on 120 hemp focus & processing acre farm Hub (GACP) Low
Slide 10: Medicinal Cannabis - Momentum Building: The Flywheel Effect
Medicinal Cannabis - Momentum building For personal use only The Flywheel Effect. Foundation Low Cost All required licenses in place, followed by GMP Further reduce cost through genetic I N V E S T O R Lower Cost Lower Prices certification and successful first harvest. research and economies of scal
Slide 11: ECS Food & Wellness
For personal use only ECS Food I N V E S T O R & Wellness. P R E S E N T A T I O N Opportunity Quality Omega 3’s Presence Value The overlap in wellness Product range is Hemp seed oil an Coles and Woolworths Transitioning and and pharmaceutical in manufactured from 100% environmentally friendly Four
Slide 12: CBD Growing Through Deregulation
Australia CBD Wellness – Special Access Scheme For personal use only Growing Through Deregulation. Europe Australia I N V E S T O R Medicinal Cannabis Pharmacy The overlap in wellness and pharmaceutical in EU provides larger offering CBD Market P R E S E N T A T I O N By 2024, the UK Medicinal Canna
Slide 13: Outlook – Contracts Building Upon Local Sales And Strong Pathway Internationally
Outlook – Contracts For personal use only Building Upon Local Sales And Strong I N V E S T O R Pathway Internationally. First customers ordering in excess of initial forecasts International contracts signed P R E S E N T A T I O N Customers spot buying Order book for dried flower exceeding current c
Slide 14: Rapid Growth Since Listing
Rapid Growth Since Listing. Sept – Dec 2021 For personal use only ▪ Large annuity contracts converted ▪ Commissioning 6 new protected cropping enclosures ▪ Maiden Tasmanian planting Aug 2021 ▪ Hemp seed to be ranged in Coles nationwide Jul 2021 I N V E S T O R ▪ $1.75m New Zealand supply agreement ▪
Slide 15: Defined Plan To Scale Up Operations To Meet Demand
Defined Plan To Scale Up For personal use only Operations To Meet Demand. Horizon 3 ▪ Economies of Scale growth ECS quality exceeds expectations and is I N V E S T O R through industrial scale comparable to high cost indoor grow cultivation, margin growth, and in house manufacturing ECS have receive
Slide 16: Building Partnerships
Building Partnerships. For personal use only Medicinial Cannabis Food & Wellness I N V E S T O R P R E S E N T A T I O N 16
Slide 17: Board Of Directors
Board Of Directors For personal use only I N V E S T O R Board Of Directors P R E S E N T A T I O N Alexander Keach David McCredie OBE Managing Director Non-Executive Chairman Michael Nitsche Jeremy King Nan-Maree Schoerie Non-Executive Director Non-Executive Director Executive Director 17
Slide 18: Highly Skilled Executive Management Team
Highly Skilled For personal use only Executive Management Team. I N V E S T O R P R E S E N T A T I O N Blaise Bratter Michael Clark Nicola Cranley Alexander Keach Business Development Head of EU Operations Finance Manager Managing Director Manager, Oceania Paul Hanrahan Jason Hine Angela Macquire N
Slide 19: Our Values
Our Values. For personal use only I N V E S T O R P R E S E N T A T I O N Patient Outcomes Sustainability Diversity Our aim is to provide the very best We operate with a low carbon footprint . Our best-in-class team are committed to Australian grown medicinal cannabis We practice organic and regener
Slide 20: Disclaimer
Disclaimer For personal use only “This Presentation may contain forward looking statements, opinions or should consider the forward looking statements contained in this I N V E S T O R estimates. Any forward looking statements, opinions or estimates Presentation in light of those disclosures. The fo
Slide 21: Contact
For personal use only E C S B O T A N I C S H O L D I N G S L T D CONTACT I N V E S T O R P R E S E N T A T I O N Suite 2, Level 15 Call us today at Email us today at 3 Spring Street 1300 169 775 hello@ecsbotanics.com.au Sydney NSW, 2000 VISIT US e c s b o t a n i c s h o l d i n g s . c o m 21
ECS Botanics Holdings — Investor Presentation (September 2021) on 6ix